CD7 and acute lymphoblastic leukemia: A parallel phase I trial is undertaken in our center to test feasibility of autologous CD7 CAR T cells against T-ALL with the same lentiviral vector, and this will provide further information to compare the application between donor and autologous CD7 CAR T cells [27].